Steve Friedman

Discovery and Pharmacological Characterization of a Novel Rodent-Active CCR2 Antagonist, INCB3344

Carrie Brodmerkel, Reid Huber, Maryanne Covington et al. · The Journal of Immunology · 2005 · 187 citations

Inflammation, Molecular Pharmacology, Cytokine +13

History of the Surveillance, Epidemiology, and End Results (SEER) Program

Steve Friedman, Serban Negoita · JNCI Monographs · 2024 · 50 citations · Full text

Cancer Management, Epidemiology Of Cancer, Databases +25

A Case Study in the Integration of Assessment and General Education: Lessons learned from a complex process

John Stone, Steve Friedman · Assessment & Evaluation in Higher Education · 2002 · 22 citations

Education, Program Evaluation, General Education Assessment +16

Pharmacokinetic–Hemodynamic Interactions Between Vasopressin and Nitroglycerin: Comparison Between Intravenous and Cutaneous Routes of Nitrate Delivery

Andrés T. Blei, Steve Friedman, Jeanne Gottstein et al. · Hepatology · 1985 · 19 citations · Full text

Conversion of an MMP-potent scaffold to an MMP-selective HER-2 sheddase inhibitor via scaffold hybridization and subtle <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si3.gif" overflow="scroll"><mml:mrow><mml:msubsup><mml:mrow><mml:mtext>P</mml:mtext></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mo>′</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:math> permutations

David Burns, Chunhong He, Yanlong Li et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 17 citations · Full text